Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apremilast: A Review in Psoriasis and Psoriatic Arthritis
Gillian M. Keating
Drugs (2017) Vol. 77, Iss. 4, pp. 459-472
Closed Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
Juan Liu, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 1-12
Closed Access | Times Cited: 69
Dual Nickel/Photoredox-Catalyzed Asymmetric Carbosulfonylation of Alkenes
Xiaoyong Du, Iván Cheng‐Sánchez, Cristina Nevado
Journal of the American Chemical Society (2023) Vol. 145, Iss. 23, pp. 12532-12540
Open Access | Times Cited: 61
Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism
Qixiang Zhao, Jiadong Yu, Hong Zhou, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 53
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics
Robert G. Petit, Amanda Cano, A. Ortiz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4983-4983
Open Access | Times Cited: 84
Interleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy
Charlie Bridgewood, Κassem Sharif, Jonathan P. Sherlock, et al.
Immunological Reviews (2020) Vol. 294, Iss. 1, pp. 27-47
Open Access | Times Cited: 79
Systemic rheumatic diseases: From biological agents to small molecules
Piercarlo Sarzi‐Puttini, Angela Ceribelli, Daniela Marotto, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 6, pp. 583-592
Open Access | Times Cited: 77
Molecular and Cellular Mechanisms of Itch in Psoriasis
Eriko Komiya, Mitsutoshi Tominaga, Yayoi Kamata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8406-8406
Open Access | Times Cited: 75
New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations
Wei Cheng, Fen Li, Jing Tian, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 2365-2380
Open Access | Times Cited: 48
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
Jiuping Zeng, Mingxing Li, Qianyun Zhao, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 6, pp. 545-562
Open Access | Times Cited: 27
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 15
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study
Amita Datta‐Mannan, Arie Regev, David E. Coutant, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 5, pp. 1152-1161
Open Access | Times Cited: 12
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 91-91
Open Access | Times Cited: 1
Biologics for the primary care physician: Review and treatment of psoriasis
Eric D. Schadler, Bernhard Ortel, Stephanie Mehlis
Disease-a-Month (2018) Vol. 65, Iss. 3, pp. 51-90
Closed Access | Times Cited: 82
Diagnosis and Management of Cutaneous Psoriasis: A Review
Alisa Brandon, Asfandyar Mufti, R. Gary Sibbald
Advances in Skin & Wound Care (2019) Vol. 32, Iss. 2, pp. 58-69
Open Access | Times Cited: 71
Biomarkers of Inflammation in Obesity-Psoriatic Patients
Carmen Rodríguez‐Cerdeira, Mónica Cordeiro-Rodríguez, Miguel Carnero-Gregorio, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 62
Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus
Anna M. Sigmund, Markus Winkler, Sophia Engelmayer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies
Gregory Livshits, Alexander Kalinkovich
Osteoarthritis and Cartilage (2017) Vol. 26, Iss. 1, pp. 7-17
Open Access | Times Cited: 53
Stratifying management of rheumatic disease for pregnancy and breastfeeding
Ian Giles, Chee‐Seng Yee, Caroline Gordon
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 7, pp. 391-402
Closed Access | Times Cited: 49
Novel nanocrystal-based formulations of apremilast for improved topical delivery
Prashantkumar K. Parmar, Arvind K. Bansal
Drug Delivery and Translational Research (2020) Vol. 11, Iss. 3, pp. 966-983
Closed Access | Times Cited: 44
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
Anna Campanati, Federico Diotallevi, Emanuela Martina, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2422-2422
Open Access | Times Cited: 23
JAK Inhibitors in Psoriatic Disease
Matteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3129-3145
Open Access | Times Cited: 15
Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System
Maria Ercu, Enno Klußmann
Journal of Cardiovascular Development and Disease (2018) Vol. 5, Iss. 1, pp. 14-14
Open Access | Times Cited: 45
New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies
Di Yan, Andrew Blauvelt, Amit K. Dey, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 10, pp. 2328-2337
Open Access | Times Cited: 27
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2713-2741
Closed Access | Times Cited: 12
cAMP: A master regulator of cadherin‐mediated binding in endothelium, epithelium and myocardium
Franziska Vielmuth, Mariya Y. Radeva, Sunil Yeruva, et al.
Acta Physiologica (2023) Vol. 238, Iss. 4
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top